Founded in 2000 and headquartered in Bagsværd, Denmark, Novozymes A/S is a biotechnology company that specializes in the research, development, production, and sale of industrial enzymes and microorganisms. Its core mission is to leverage biological solutions to improve industrial processes, enhance food production, and support animal health. Novozymes operates within three main market segments: technical enzymes, food enzymes, and animal feed enzymes, with a global distribution network and online sales and service centers.
Notable figures associated with Novozymes include Chairman Cees de Jong and President and CEO Ester Baiget. The company has achieved significant financial success, reporting a revenue of 17.5 billion kr. in 2022. Novozymes recently merged with Chr. Hansen to form Novonesis, further solidifying its position as a leading biosolutions partner. This merger aims to transform global production, consumption, and living standards through innovative biological solutions, marking a substantial impact on the biotechnology industry.
